Sionna Therapeutics, Inc. (SION)

5.96 -1.22 (-16.99%) USD  |  NASDAQ  |  Sep 18, 16:00
6.09 +0.13 (+2.18%) After-Hours: 06:34
More

Sionna Therapeutics Total Long Term Debt (Quarterly) : 6.692M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for SION.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 6.692M
March 31, 2026 7.055M
December 31, 2025 7.408M
September 30, 2025 7.751M
June 30, 2025 8.069M
March 31, 2025 8.378M
Date Value
December 31, 2024 8.677M
September 30, 2024 8.968M
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 9.749M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 1.978B
Capricor Therapeutics, Inc. 89.56M
ARS Pharmaceuticals, Inc. 96.68M
ACADIA Pharmaceuticals, Inc. 59.55M
Immunic, Inc. 0.328M